We are live on
!
Find out more
Takeda Pharmaceutical
358 hedge funds and large institutions have $1.82B invested in Takeda Pharmaceutical in 2026 Q1 according to their latest regulatory filings, with 56 funds opening new positions, 174 increasing their positions, 58 reducing their positions, and 38 closing their positions.
New
Increased
Maintained
Reduced
Closed
2,078% more call options, than puts
Call options by funds: $30.6M | Put options by funds: $1.41M
200% more repeat investments, than reductions
Existing positions increased: 174 | Existing positions reduced: 58
47% more first-time investments, than exits
New positions opened: 56 | Existing positions closed: 38
39% more capital invested
Capital invested by funds: $1.31B → $1.82B (+$511M)
3% more funds holding
Funds holding: 348 → 358 (+10)
0.45% more ownership
Funds ownership: 2.63% → 3.09% (+0.45%)
Holders
358
Holders Change
+10
Holders Change %
+2.87%
% of All Funds
4.41%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.01%
New
56
Increased
174
Reduced
58
Closed
38
Calls
$30.6M
Puts
$1.41M
Net Calls
+$29.2M
Net Calls Change
-$842K
Top Buyers
| 1 |
Adage Capital Partners
Boston,
Massachusetts
|
+$113M |
| 2 |
Capital Research Global Investors
Los Angeles,
California
|
+$98.6M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
+$53.7M |
| 4 |
CWP
Capital Wealth Planning
Naples,
Florida
|
+$15.6M |
| 5 |
Goldman Sachs
New York
|
+$14.3M |
Top Sellers
| 1 |
Arrowstreet Capital
Boston,
Massachusetts
|
-$45M |
| 2 |
D.E. Shaw & Co
New York
|
-$29.7M |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$24.3M |
| 4 |
Voloridge Investment Management
Jupiter,
Florida
|
-$15M |
| 5 |
Millennium Management
New York
|
-$13.9M |